On Manifold, a prediction market platform, forecasters have placed a 29% probability on the outcome that blinded study participants will successfully detect whether they are consuming an indica or sativa strain. The market, which has attracted 14 traders, reflects growing skepticism among some researchers and consumers about the scientific validity of the traditional cannabis classification system, which is based on plant morphology rather than chemical composition.
No specific external trigger was identified in today's news flow to explain this probability. The low confidence in the study's success aligns with recent scientific literature suggesting that the chemical profiles of cannabis—particularly cannabinoid and terpene content—may be more predictive of effects than the indica/sativa label. The market's outcome will be determined by the results of a yet-to-be-conducted blinded trial, with the resolution date set for early 2026.